N. Upton - Concepedia

Author

N. Upton

GlaxoSmithKline (United Kingdom)

Also Known As

N UPTON, N Upton, N. UPTON, N. Upton, Natalie F. Upton, Neil Upton

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)Molecular Discovery (United Kingdom)New Frontier Queen's Medical Centre University of Liverpool

About

N. Upton is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	22	2.2K
2	Social Sciences	10	10	991
3	Health Sciences	6	6	488
4	Natural Sciences	1	1	12
5	Allergy	1	1	42

N. Upton

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist G.A. Kennett, Martyn Wood, Fiona Bright, Neuropharmacology Sb 242084Molecular PharmacologyFunctional SelectivityMedicineReceptor Antagonist	1997	523
Orexin-A, an hypothalamic peptide with analgesic properties Sharon Bingham, Philip T. Davey, Adam J. Babbs, Pain Pain MedicineHypothalamic Peptide Orexin-aNeuropathic PainMolecular PainHypothalamic Peptide	2001	266
SB‐334867, a selective orexin‐1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin‐A in rats R.J. Rodgers, Jason C. G. Halford, Ricardo Luiz Nunes‐de‐Souza, European Journal of Neuroscience Food IntakeBehavioural SatietySynaptic SignalingSocial SciencesContinuous Monitoring Technique	2001	230
Resocialisation of isolation-reared rats does not alter their anxiogenic profile on the elevated X-maze model of anxiety Ian K. Wright, N. Upton, C.A. Marsden Physiology & Behavior Experimental PsychopathologyPsychiatryBehavioral NeuroscienceIsolation-reared RatsBehavioural Pharmacology	1991	178
Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze Ian K. Wright, N. Upton, C.A. Marsden Psychopharmacology Neurobiological MechanismNeuropsychologyPsychiatryNeurophysiologyBehavioral Neuroscience	1992	135
The PPARγ agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B Leann P. Quinn, Barry Crook, Mark Hows, British Journal of Pharmacology	2008	118
Effect of isolation rearing on 5-HT agonist-induced responses in the rat Ian K. Wright, Hammad Ismail, N. Upton, Psychopharmacology Behavioral NeuroscienceMedicineBehavioural PharmacologyPhysiologyBehavioral Pharmacology	1991	98
Evidence implicating a role for orexin-1 receptor modulation of paradoxical sleep in the rat M.I Smith, D.C Piper, Mark Duxon, Neuroscience Letters Orexin-1 Receptor ModulationSleep DisordersSleepParadoxical SleepSleep Disorder	2003	85
BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties Thomas P. Blackburn, Gordon S. Baxter, G.A. Kennett, Psychopharmacology Functional SelectivityMedicineMechanism Of ActionMolecular BiologyPharmacological Agent	1993	70
Repetitive Cortical Spreading Depression in a Gyrencephalic Feline Brain: Inhibition by the Novel Benzoylamino-Benzopyran SB-220453 MI Smith, SJ Read, W N Chan, Cephalalgia NeurotransmitterNeuromodulation TherapiesRepetitive Sd ActivityNeurotransmissionSocial Sciences	2000	69

Page 1